Back to Portfolio
Development Pre-Money
Cryo Medica
Oncology
Cryo Medica has developed a novel platform, needle and service model that can be seamlessly integrated into Doctor’s Offices, Surgical Centers and Hospitals with increased effectiveness and comfort for all stakeholders. Along with Prostate Cancer, Cryo Ablation is used to treat Kidney Tumors, Breast, Liver and Lung with reimbursement established.
Development Pre-Money
Cryo Medica
Oncology
Cryo Medica has developed a novel platform, needle and service model that can be seamlessly integrated into Doctor’s Offices, Surgical Centers and Hospitals with increased effectiveness and comfort for all stakeholders. Along with Prostate Cancer, Cryo Ablation is used to treat Kidney Tumors, Breast, Liver and Lung with reimbursement established.
Development Pre-Money
Cryo Medica
Oncology
Cryo Medica has developed a novel platform, needle and service model that can be seamlessly integrated into Doctor’s Offices, Surgical Centers and Hospitals with increased effectiveness and comfort for all stakeholders. Along with Prostate Cancer, Cryo Ablation is used to treat Kidney Tumors, Breast, Liver and Lung with reimbursement established.
The opportunity
Cancer ablation is not a new technique, with Boston Scientific dominating Prostate market after their acquisition of Galil Medical. A smaller more nimble system was needed to move the therapy out of the hospital to outpatient clinics and urology offices.
The solution
A portable Cryo Ablation system for the treatment of Prostate and other cancers. Moves treatment to the clinic and practice. Significant revenue opportunity for Urologists under current approved reimbursement codes . Portable vs cart based, enabling HASS model.
The opportunity
Cancer ablation is not a new technique, with Boston Scientific dominating Prostate market after their acquisition of Galil Medical. A smaller more nimble system was needed to move the therapy out of the hospital to outpatient clinics and urology offices.
The solution
A portable Cryo Ablation system for the treatment of Prostate and other cancers. Moves treatment to the clinic and practice. Significant revenue opportunity for Urologists under current approved reimbursement codes . Portable vs cart based, enabling HASS model.
The opportunity
Cancer ablation is not a new technique, with Boston Scientific dominating Prostate market after their acquisition of Galil Medical. A smaller more nimble system was needed to move the therapy out of the hospital to outpatient clinics and urology offices.
The solution
A portable Cryo Ablation system for the treatment of Prostate and other cancers. Moves treatment to the clinic and practice. Significant revenue opportunity for Urologists under current approved reimbursement codes . Portable vs cart based, enabling HASS model.
350+
men die yearly due to prostate cancer
60%
of newly diagnosed men are candidates for targeted therapy
70 - 90%
survival rate without any biochemical treatment
350+
men die yearly due to prostate cancer
60%
of newly diagnosed men are candidates for targeted therapy
70 - 90%
survival rate without any biochemical treatment
350+
men die yearly due to prostate cancer
60%
of newly diagnosed men are candidates for targeted therapy
70 - 90%
survival rate without any biochemical treatment
ARTICLES
Press
Inside New Lab, an 84,000-Square-Foot Tech Paradise in Brooklyn
Aug 8, 2016
Once a bustling shipbuilding hub, Building 128 at the Brooklyn Navy Yard has been transformed into New Lab—an 84,000-square-foot innovation center.
Press
Incubators Aren't Only for Tech Startups
May 14, 2014
When we think of incubators, tech startups often come to mind—but today’s incubators are more diverse and community-focused than ever.
Press
Re-Making Manufacturing in the United States
Mar 10, 2014
The U.S. manufacturing industry is experiencing a renaissance, shifting from traditional mass production to advanced, innovation-driven processes.
Press
Inside New Lab, an 84,000-Square-Foot Tech Paradise in Brooklyn
Aug 8, 2016
Once a bustling shipbuilding hub, Building 128 at the Brooklyn Navy Yard has been transformed into New Lab—an 84,000-square-foot innovation center.
Press
Incubators Aren't Only for Tech Startups
May 14, 2014
When we think of incubators, tech startups often come to mind—but today’s incubators are more diverse and community-focused than ever.
Press
Re-Making Manufacturing in the United States
Mar 10, 2014
The U.S. manufacturing industry is experiencing a renaissance, shifting from traditional mass production to advanced, innovation-driven processes.
Press
Inside New Lab, an 84,000-Square-Foot Tech Paradise in Brooklyn
Aug 8, 2016
Once a bustling shipbuilding hub, Building 128 at the Brooklyn Navy Yard has been transformed into New Lab—an 84,000-square-foot innovation center.
Press
Incubators Aren't Only for Tech Startups
May 14, 2014
When we think of incubators, tech startups often come to mind—but today’s incubators are more diverse and community-focused than ever.
